Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials (Q38072063)

28 August 2017

1 reference

title

Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials (English)

1 reference

28 August 2017

2

Lars V Kessing

0 references

Maj Vinberg

series ordinal

3

object named as

Maj Vinberg

1 reference

28 August 2017

Leda Abbasowa

1

1 reference

28 August 2017

7 January 2013

1 reference

Nordic Journal of Psychiatry

28 August 2017

1 reference

28 August 2017

67

1 reference

28 August 2017

6

1 reference

28 August 2017

369-382

1 reference

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies

28 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Pharmacological approaches to the treatment of residual symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Do individuals with former amphetamine dependence have cognitive deficits?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Psychostimulants in the treatment of depression : a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Update on augmentation of antidepressant response in resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

A surveillance method for the early identification of idiosyncratic adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil: a review of neurochemical actions and effects on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Approved and investigational uses of modafinil : an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil reduces microsleep during partial sleep deprivation in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Phenelzine and dexamphetamine in depressive illness. A comparative trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

IMIPRAMINE AND "DRINAMYL" IN DEPRESSIVE ILLNESS: A COMPARATIVE TRIAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

A prospective trial of modafinil as an adjunctive treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil monotherapy in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Treatment of acute mania with modafinil monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

Are psychostimulants a treatment option in mania?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.752035

10.3109/08039488.2012.752035

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23293898